Zimmer Biomet Holdings logo

Zimmer Biomet Holdings

ZBHNYSEStock Fundamentals

Zimmer Biomet is a global medical technology leader specializing in musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, robotic surgical systems, and digital health solutions aimed at improving patient mobility and health outcomes. Its core value proposition centers on a comprehensive portfolio that integrates traditional implants with advanced data analytics and artificial intelligence.

Market Cap$16.0B
Revenue TTM$8.4B
Net Income TTM$761.1M
P/E Ratio21.05
Net Margin9.05%
EPS TTM$3.86
Free Cash Flow TTM$1.5B
Employees18.0K
CEOIvan Tornos
CountryUnited States of America
Healthcare
Medical - Devices
SegmentsMedical Devices, Orthopedics, Health Technology
Business ModelsManufacturing, Direct Sales, Consignment, Distributor-based sales
Most Recent EarningsApr 28, 2026 · 1 month 4 days agoQ1 2026
View report
Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Gross Margin70.03%
Op. Margin14.02%
ROE6.07%
D/E58.95%
Current Ratio1.73
Total Debt$7.5B
Cash$424.2M
CapEx TTM$216.2M

Gross Profit

View metric

Net Income

View metric

Operating Cash Flow

View metric

Free Cash Flow

View metric

EPS (Diluted)

View metric

Business Segments

Knees

primary

Products for first-time (primary) and revision joint replacement procedures, as well as partial knee reconstructions for limited degeneration.

Products

Persona Knee, NexGen Knee Implants, Vanguard Knee, Oxford Partial Knee, ROSA Robot

Customers

Orthopedic surgeons, Hospitals, Ambulatory surgery centers

Hips

major

Systems for total hip replacement that replace the femoral head and acetabulum, utilizing both cemented and press-fit fixation technologies.

Products

Taperloc Hip System, Avenir Complete Hip System, Z1 Hip Implant, Arcos Modular Hip System, G7 Acetabular System, ROSA Robot

Customers

Orthopedic surgeons, Healthcare institutions, Stocking distributors

S.E.T. (Sports Medicine, Extremities, Trauma, Biologics and CMFT)

major

A diverse category covering soft tissue repair, joint preservation, fracture stabilization, and craniomaxillofacial and thoracic reconstruction.

Products

JuggerKnot Soft Anchor System, Gel-One Cross-linked Hyaluronate, Gorilla Ankle Fracture Plating System, Comprehensive Shoulder, Natural Nail System, SternaLock System, ROSA Robot

Customers

Orthopedic specialists, Neurosurgeons, Trauma centers, Sports medicine clinics

Technology & Data, Bone Cement and Surgical

moderate

A suite of integrated digital and robotic technologies alongside traditional surgical supplies and fixation materials.

Products

ZBEdge Platform, ROSA Robot, Bone cement, Surgical solutions

Customers

Healthcare institutions, Surgical teams, Group purchasing organizations

Segment Financials

Knees — Revenue

View metric

Hips — Revenue

View metric

Technology And Data Bone Cement And Surgical — Revenue

View metric

SET — Revenue

View metric

EMEA — Cost of Goods Sold

View metric

EMEA — Research And Development Expense Excluding Acquired In Process Cost

View metric

Business Overview

Competitive Position

A global leader in the musculoskeletal market with a dominant position in knee and hip reconstruction and an increasing focus on robotic-assisted surgery.

Geographies

United States, Europe, Middle East, Africa, Asia Pacific

Customer Segments

Hospitals, Ambulatory Surgery Centers, Specialist Physicians, Group Purchasing Organizations

Upstream Dependencies

Raw material suppliers, Specialized component manufacturers, Technology licensing partners, Third-party logistics providers

Downstream Customers

Hospitals, Ambulatory surgery centers, Orthopedic surgeons, Stocking distributors, Healthcare dealers

Zimmer Biomet Holdings logo

Zimmer Biomet Holdings FAQ

Common questions about Zimmer Biomet Holdings

Zimmer Biomet is a global medical technology leader specializing in musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, robotic surgical systems, and digital health solutions aimed at improving patient mobility and health outcomes. Its core value proposition centers on a comprehensive portfolio that integrates traditional implants with advanced data analytics and artificial intelligence.

Zimmer Biomet Holdings (ZBH) has a market capitalization of $16.0B and trades on NYSE.

Zimmer Biomet Holdings generated $8.4B in trailing twelve-month revenue with net income of $761.1M, representing a net margin of 9.0%. Gross margin stands at 70.0%, with free cash flow of $1.5B. These figures are based on the Q1 2026 filing.

Zimmer Biomet Holdings's key competitors include Stryker Corporation, Medtronic plc, Johnson & Johnson MedTech, and others. These companies compete in similar markets and product categories.

Zimmer Biomet Holdings has approximately 18,000 employees.